Programme of Acromegaly Screening in Patients With Associated Somatic Disorders

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

367 participants

Study Classification

OBSERVATIONAL

Study Start Date

2013-12-05

Study Completion Date

2015-09-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The primary objective of the protocol is to define percentage of patients with acromegaly in relation to the total number of screened patients with confirmed clinically significant set of associated somatic disorders with the help of laboratory (Insulin-like Growth Factor I, Growth Hormone, Oral Glucose-Tolerance Test \[IGF-1, GH, OGTT\]) and instrumental examination methods (Magnetic Resonance Imaging \[MRI\]).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Complications in Hypertension and Obesity

NCT00552292

Metabolic Syndrome Hypertension Obesity +2 more

UNKNOWN

"The Effect of Comprehensive Non-pharmacological Treatment on Metabolic Disorders in Type 2 Diabetic Patients"

NCT04632823

Type 2 Diabetes

UNKNOWN NA

Relationship of Metabolic Syndrome and Its Components With Thyroid Nodule(s)

NCT03009279

Metabolic Syndrome Thyroid Nodule

UNKNOWN

Effect of MetS* on Cognitive Performance and Physical Activity (Metabolic Syndrome)

NCT05702437

Metabolic Syndrome

RECRUITING

Fertility and Cardiovascular Risk in Men With Metabolic Syndrome

NCT03977064

Metabolic Syndrome

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acromegaly

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Acromegaly patients

Non-interventional cross-sectional survey

Intervention Type OTHER

This is a survey which does not involve any intervention into routine clinical practice, including the use of any investigational therapy or special examination methods.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Non-interventional cross-sectional survey

This is a survey which does not involve any intervention into routine clinical practice, including the use of any investigational therapy or special examination methods.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Men and women aged 18 years and above with associated somatic disorders observed at the Moscow Endocrinology dispensary or Endocrinology Hospital at First Moscow State Medical University
* Patients who signed the Informed Consent Form for participation in the survey before collection of any information.